BREWIN DOLPHIN LTD - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2021$36,449
+21.4%
7,0500.0%0.00%0.0%
Q2 2021$30,033
+1145.1%
7,050
+1075.0%
0.00%
Q2 2019$2,412
-6.5%
6000.0%0.00%
Q1 2019$2,580
-25.2%
6000.0%0.00%
Q4 2018$3,450
-57.6%
6000.0%0.00%
-100.0%
Q3 2018$8,136
+14.2%
6000.0%0.00%0.0%
Q2 2018$7,122
+5.7%
6000.0%0.00%0.0%
Q1 2018$6,738
+68.1%
6000.0%0.00%
Q4 2017$4,008
-18.4%
6000.0%0.00%
-100.0%
Q3 2017$4,9146000.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
NEA Management Company, LLC 12,025,999$66,263,0002.30%
Abingworth LLP 250,000$1,375,0001.02%
Tekla Capital Management LLC 1,466,368$8,080,0000.31%
Rock Springs Capital Management LP 875,000$4,821,0000.28%
QVT Financial LP 1,360,647$6,940,0000.22%
Vident Investment Advisory, LLC 232,641$1,282,0000.13%
Hillhouse Capital Management 1,190,476$6,560,0000.13%
Orbimed Advisors 1,914,660$10,550,0000.12%
Granite Investment Partners, LLC 195,571$1,078,0000.07%
Monashee Investment Management LLC 25,000$138,0000.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders